Drug Effectiveness of 2nd and 3rd TNF Inhibitors in Psoriatic Arthritis - Relationship with the Reason for Withdrawal from the Previous Treatment
Lykke Midtboll Ornbjerg,Cecilie Heegaard Brahe,Louise Linde,Lennart Jacobsson,Michael J. Nissen,Eirik Klami Kristianslund,Maria Jose Santos,Dan Nordstrom,Ziga Rotar,Bjorn Gudbjornsson,Fatos Onen,Catalin Codreanu,Ulf Lindstrom,Burkhard Moller,Tore K. Kvien,Anabela Barcelos,Kari K. Eklund,Matija Tomsic,Thorvardur Jon Love,Gercek Can,Ruxandra Ionescu,Anne Gitte Loft,Herman Mann,Karel Pavelka,Marleen van de Sande,I. E. van der Horst-Bruinsma,Manuel Pombo Suarez,Carlos Sanchez-Piedra,Gary J. Macfarlane,Florenzo Iannone,Brigitte Michelsen,Lise Hejl Hyldstrup,Niels Steen Krogh,Mikkel Ostergaard,Merete Lund Hetland Joint Bone Spine（2024）
Key words
Psoriatic arthritis,TNF-inhibitors,Epidemiology,Treatment withdrawal
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper